Trial intelligence / Profile preview

Sericin and Turmeric Cream in Psoriasis

NCT06482398Not yet recruiting

Sponsor
Chulalongkorn University
Start
Jul 2024
Primary completion
Jun 2025
Modality
Transdermal Patches, Recombinant Proteins and Enzymes, Hydrogel Systems
01

Overview

Randomised trial of sericin cream and turmeric extract cream in psoriasis (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Psoriasis Area and Severity Index at 8 weeks. Planned start Jul 2024; status: not yet recruiting.

02

Drugs

sericin creamturmeric extract cream
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT06482398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06482398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call